Follow the people · Insider
Gilbert H. Kliman
Gilbert H. Kliman files insider transactions with the SEC as a director of Glaukos (GKOS). We hold 3 disclosed purchases and sales filed since 9 January 2006, 1 of them in the last 90 days.
- Files forGKOS
- Disclosed buys and sells3 in all, 1 in the last 90 days
- Last disclosure20 August 2026
Positions held
14 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 30 June 2015 — 19 August 2026Director · Glaukos (GKOS)95 Form 4 lines · source: SEC Form 4
- Filed 1 June 2020 — 1 December 2023Director · Staar Surgical Co (STAA)9 Form 4 lines · source: SEC Form 4
- Filed 28 June 2021 — 2 August 2022Other role · Doximity (DOCS)26 Form 4 lines · source: SEC Form 4
- Filed 19 November 2021 — 19 November 202110% owner · Braze (BRZE)9 Form 4 lines · source: SEC Form 4
- Filed 25 September 2020 — 13 July 202110% owner · PMV Pharmaceuticals (PMVP)15 Form 4 lines · source: SEC Form 4
- Filed 7 November 2019 — 7 November 2019Director and 10% owner · Venus Concept (VERO)2 Form 4 lines · source: SEC Form 4
- Filed 11 October 2017 — 20 August 2019Director and 10% owner · Restoration Robotics (HAIR)10 Form 4 lines · source: SEC Form 4
- Filed 19 February 2019 — 14 June 2019Director and 10% owner · Avedro (AVDR)9 Form 4 lines · source: SEC Form 4
- Filed 18 October 2018 — 18 October 201810% owner · Eiger BioPharmaceuticals (EIGR)2 Form 4 lines · source: SEC Form 4
- Filed 23 August 2018 — 23 August 201810% owner · Obalon Therapeutics (OBLN)1 Form 4 line · source: SEC Form 4
- Filed 18 September 2013 — 25 February 201410% owner · Marketo (MKTO)11 Form 4 lines · source: SEC Form 4
- Filed 7 February 2011 — 7 February 2011DirectorOther · Epocrates (EPOC)14 Form 4 lines · source: SEC Form 4
- Filed 5 January 2006 — 2 April 2007Director · Intralase (ILSE)22 Form 4 lines · source: SEC Form 4
- Filed 9 March 2006 — 17 March 200610% owner · Corgentech (CGTK)5 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 2,500 shares of GlaukosSEC Form 420 August 2026Common Stock · traded 19 August 2026 · filed 20 August 2026
- ▼ sold on the open market 2,500 shares of GlaukosSEC Form 420 August 2026Common Stock · traded 19 August 2026 · filed 20 August 2026
- exercised options over 2,500 shares of Glaukos (a derivative holding)SEC Form 420 August 2026Stock Option (Right to Buy) · traded 19 August 2026 · filed 20 August 2026
- was granted 2,987 shares of Glaukos (a derivative holding)SEC Form 423 June 2026Stock Option (Right to Buy) · traded 28 May 2026 · filed 23 June 2026
- was granted 1,878 shares of GlaukosSEC Form 41 June 2026Common Stock · traded 28 May 2026 · filed 1 June 2026
- was granted 2,987 shares of Glaukos (a derivative holding)SEC Form 41 June 2026Stock Option (Right to Buy) · traded 28 May 2026 · filed 1 June 2026
- exercised options over 5,000 shares of GlaukosSEC Form 418 May 2026Common Stock · traded 14 May 2026 · filed 18 May 2026
- ▼ sold on the open market 5,000 shares of GlaukosSEC Form 418 May 2026Common Stock · traded 14 May 2026 · filed 18 May 2026
- exercised options over 5,000 shares of Glaukos (a derivative holding)SEC Form 418 May 2026Stock Option (Right to Buy) · traded 14 May 2026 · filed 18 May 2026
- exercised options over 5,000 shares of GlaukosSEC Form 413 May 2026Common Stock · traded 11 May 2026 · filed 13 May 2026
- ▼ sold on the open market 5,000 shares of GlaukosSEC Form 413 May 2026Common Stock · traded 11 May 2026 · filed 13 May 2026
- exercised options over 5,000 shares of Glaukos (a derivative holding)SEC Form 413 May 2026Stock Option (Right to Buy) · traded 11 May 2026 · filed 13 May 2026
- was granted 623 shares of GlaukosSEC Form 47 January 2026Common Stock · traded 2 January 2026 · filed 7 January 2026
- was granted 623 shares of GlaukosSEC Form 47 January 2026Common Stock · traded 2 January 2026 · filed 7 January 2026
- exercised options over 5,000 shares of Glaukos (a derivative holding)SEC Form 411 December 2025Stock Option (Right to Buy) · traded 9 December 2025 · filed 11 December 2025
- exercised options over 5,000 shares of GlaukosSEC Form 411 December 2025Common Stock · traded 9 December 2025 · filed 11 December 2025
- ▼ sold on the open market 5,000 shares of GlaukosSEC Form 411 December 2025Common Stock · traded 9 December 2025 · filed 11 December 2025
- was granted 3,149 shares of Glaukos (a derivative holding)SEC Form 42 June 2025Stock Option (Right to Buy) · traded 29 May 2025 · filed 2 June 2025
- was granted 461 shares of GlaukosSEC Form 42 June 2025Common Stock · traded 2 January 2025 · filed 2 June 2025
- was granted 2,108 shares of GlaukosSEC Form 42 June 2025Common Stock · traded 29 May 2025 · filed 2 June 2025
- exercised options over 10,000 shares of Glaukos (a derivative holding)SEC Form 423 December 2024Stock Option (Right to Buy) · traded 20 December 2024 · filed 23 December 2024
- exercised options over 10,000 shares of GlaukosSEC Form 423 December 2024Common Stock · traded 20 December 2024 · filed 23 December 2024
- ▼ sold on the open market 10,000 shares of GlaukosSEC Form 423 December 2024Common Stock · traded 20 December 2024 · filed 23 December 2024
- exercised options over 2,000 shares of Glaukos (a derivative holding)SEC Form 413 December 2024Stock Option (Right to Buy) · traded 11 December 2024 · filed 13 December 2024
- exercised options over 2,000 shares of GlaukosSEC Form 413 December 2024Common Stock · traded 11 December 2024 · filed 13 December 2024
- ▼ sold on the open market 2,000 shares of GlaukosSEC Form 413 December 2024Common Stock · traded 11 December 2024 · filed 13 December 2024
- exercised options over 3,000 shares of Glaukos (a derivative holding)SEC Form 411 September 2024Stock Option (Right to Buy) · traded 9 September 2024 · filed 11 September 2024
- exercised options over 3,000 shares of GlaukosSEC Form 411 September 2024Common Stock · traded 9 September 2024 · filed 11 September 2024
- ▼ sold on the open market 2,000 shares of GlaukosSEC Form 411 September 2024Common Stock · traded 9 September 2024 · filed 11 September 2024
- ▼ sold on the open market 1,000 shares of GlaukosSEC Form 411 September 2024Common Stock · traded 9 September 2024 · filed 11 September 2024
- exercised options over 5,000 shares of Glaukos (a derivative holding)SEC Form 43 June 2024Stock Option (Right to Buy) · traded 30 May 2024 · filed 3 June 2024
- was granted 1,246 shares of Glaukos (a derivative holding)SEC Form 43 June 2024Stock Option (Right to Buy) · traded 30 May 2024 · filed 3 June 2024
- exercised options over 5,000 shares of GlaukosSEC Form 43 June 2024Common Stock · traded 30 May 2024 · filed 3 June 2024
- ▼ sold on the open market 5,000 shares of GlaukosSEC Form 43 June 2024Common Stock · traded 30 May 2024 · filed 3 June 2024
- was granted 1,716 shares of GlaukosSEC Form 43 June 2024Common Stock · traded 30 May 2024 · filed 3 June 2024
- exercised options over 5,000 shares of Glaukos (a derivative holding)SEC Form 48 March 2024Stock Option (Right to Buy) · traded 7 March 2024 · filed 8 March 2024
- ▼ sold on the open market 3,145 shares of GlaukosSEC Form 48 March 2024Common Stock · traded 6 March 2024 · filed 8 March 2024
- ▼ sold on the open market 5,202 shares of GlaukosSEC Form 48 March 2024Common Stock · traded 6 March 2024 · filed 8 March 2024
- exercised options over 5,000 shares of GlaukosSEC Form 48 March 2024Common Stock · traded 7 March 2024 · filed 8 March 2024
- ▼ sold on the open market 5,000 shares of GlaukosSEC Form 48 March 2024Common Stock · traded 7 March 2024 · filed 8 March 2024
- ▼ sold on the open market 8,000 shares of GlaukosSEC Form 429 February 2024Common Stock · traded 27 February 2024 · filed 29 February 2024
- was granted 895 shares of GlaukosSEC Form 44 January 2024Common Stock · traded 2 January 2024 · filed 4 January 2024
- was granted 366 shares of Staar Surgical CoSEC Form 44 December 2023Common Stock · traded 1 December 2023 · filed 4 December 2023
- was granted 435 shares of Staar Surgical CoSEC Form 43 October 2023Common Stock · traded 29 September 2023 · filed 3 October 2023
- exercised options over 10,000 shares of Glaukos (a derivative holding)SEC Form 48 August 2023Stock Option (Right to Buy) · traded 4 August 2023 · filed 8 August 2023
- exercised options over 10,000 shares of GlaukosSEC Form 48 August 2023Common Stock · traded 4 August 2023 · filed 8 August 2023
- ▼ sold on the open market 10,000 shares of GlaukosSEC Form 48 August 2023Common Stock · traded 4 August 2023 · filed 8 August 2023
- exercised options over 3,417 shares of Staar Surgical CoSEC Form 416 June 2023Common Stock · traded 15 June 2023 · filed 16 June 2023
- was granted 3,230 shares of GlaukosSEC Form 45 June 2023Common Stock · traded 1 June 2023 · filed 5 June 2023
- was granted 1,572 shares of GlaukosSEC Form 44 January 2023Common Stock · traded 3 January 2023 · filed 4 January 2023
- acquired or disposed of, other 2,382 shares of GlaukosSEC Form 419 August 2022Common Stock · traded 19 August 2022 · filed 19 August 2022
- acquired or disposed of, other 2,382 shares of GlaukosSEC Form 419 August 2022Common Stock · traded 19 August 2022 · filed 19 August 2022
- acquired or disposed of, other 333,917 shares of GlaukosSEC Form 48 August 2022Common Stock · traded 4 August 2022 · filed 8 August 2022
- acquired or disposed of, other 83,955 shares of GlaukosSEC Form 48 August 2022Common Stock · traded 4 August 2022 · filed 8 August 2022
- acquired or disposed of, other 83,955 shares of GlaukosSEC Form 48 August 2022Common Stock · traded 4 August 2022 · filed 8 August 2022
- acquired or disposed of, other 19,045 shares of GlaukosSEC Form 48 August 2022Common Stock · traded 4 August 2022 · filed 8 August 2022
- ▼ sold on the open market 3,362 shares of GlaukosSEC Form 48 August 2022Common Stock · traded 5 August 2022 · filed 8 August 2022
- returned to the issuer 4,714 shares of DoximitySEC Form 45 August 2022Class A Common Stock · traded 2 August 2022 · filed 5 August 2022
- was granted 4,714 shares of DoximitySEC Form 429 July 2022Class A Common Stock · traded 27 July 2022 · filed 29 July 2022
- exercised options over 355 shares of Staar Surgical CoSEC Form 417 June 2022Common Stock · traded 16 June 2022 · filed 17 June 2022
- exercised options over 2,899 shares of Staar Surgical CoSEC Form 417 June 2022Common Stock · traded 16 June 2022 · filed 17 June 2022
- was granted 4,364 shares of GlaukosSEC Form 46 June 2022Common Stock · traded 2 June 2022 · filed 6 June 2022
- acquired or disposed of, other 980 shares of GlaukosSEC Form 418 May 2022Common Stock · traded 18 May 2022 · filed 18 May 2022
- acquired or disposed of, other 980 shares of GlaukosSEC Form 418 May 2022Common Stock · traded 18 May 2022 · filed 18 May 2022
- ▼ sold on the open market 29,174 shares of DoximitySEC Form 425 February 2022Class A Common Stock · traded 23 February 2022 · filed 25 February 2022
- ▼ sold on the open market 826 shares of DoximitySEC Form 425 February 2022Class A Common Stock · traded 25 February 2022 · filed 25 February 2022
- ▼ sold on the open market 8,912 shares of DoximitySEC Form 48 December 2021Class A Common Stock · traded 7 December 2021 · filed 8 December 2021
- ▼ sold on the open market 5,980 shares of DoximitySEC Form 48 December 2021Class A Common Stock · traded 7 December 2021 · filed 8 December 2021
- converted 4,300,000 shares of Doximity (a derivative holding)SEC Form 46 December 2021Class B Common Stock · traded 2 December 2021 · filed 6 December 2021
- converted 4,300,000 shares of DoximitySEC Form 46 December 2021Class A Common Stock · traded 2 December 2021 · filed 6 December 2021
- acquired or disposed of, other 4,300,000 shares of DoximitySEC Form 46 December 2021Class A Common Stock · traded 2 December 2021 · filed 6 December 2021
- acquired or disposed of, other 1,101,094 shares of DoximitySEC Form 46 December 2021Class A Common Stock · traded 2 December 2021 · filed 6 December 2021
- acquired or disposed of, other 1,101,094 shares of DoximitySEC Form 46 December 2021Class A Common Stock · traded 2 December 2021 · filed 6 December 2021
- acquired or disposed of, other 249,778 shares of DoximitySEC Form 46 December 2021Class A Common Stock · traded 2 December 2021 · filed 6 December 2021
- ▼ sold on the open market 2,000 shares of DoximitySEC Form 46 December 2021Class A Common Stock · traded 3 December 2021 · filed 6 December 2021
- converted 2,824,395 shares of Braze (a derivative holding)SEC Form 423 November 2021Series B Preferred Stock · traded 19 November 2021 · filed 23 November 2021
- converted 1,603,848 shares of Braze (a derivative holding)SEC Form 423 November 2021Series C Preferred Stock · traded 19 November 2021 · filed 23 November 2021
- converted 95,976 shares of Braze (a derivative holding)SEC Form 423 November 2021Series D Preferred Stock · traded 19 November 2021 · filed 23 November 2021
- acquired or disposed of, other 4,524,219 shares of Braze (a derivative holding)SEC Form 423 November 2021Class B Common Stock · traded 19 November 2021 · filed 23 November 2021
- converted 1,130,000 shares of Braze (a derivative holding)SEC Form 423 November 2021Class B Common Stock · traded 19 November 2021 · filed 23 November 2021
- converted 4,524,219 shares of BrazeSEC Form 423 November 2021Common Stock · traded 19 November 2021 · filed 23 November 2021
- acquired or disposed of, other 4,524,219 shares of BrazeSEC Form 423 November 2021Common Stock · traded 19 November 2021 · filed 23 November 2021
- converted 1,130,000 shares of BrazeSEC Form 423 November 2021Class A Common Stock · traded 19 November 2021 · filed 23 November 2021
- ▼ sold on the open market 1,130,000 shares of BrazeSEC Form 423 November 2021Class A Common Stock · traded 19 November 2021 · filed 23 November 2021
- converted 4,300,000 shares of Doximity (a derivative holding)SEC Form 415 November 2021Class B Common Stock · traded 12 November 2021 · filed 15 November 2021
- converted 4,300,000 shares of DoximitySEC Form 415 November 2021Class A Common Stock · traded 12 November 2021 · filed 15 November 2021
- acquired or disposed of, other 4,300,000 shares of DoximitySEC Form 415 November 2021Class A Common Stock · traded 12 November 2021 · filed 15 November 2021
- acquired or disposed of, other 1,089,179 shares of DoximitySEC Form 415 November 2021Class A Common Stock · traded 12 November 2021 · filed 15 November 2021
- acquired or disposed of, other 1,089,179 shares of DoximitySEC Form 415 November 2021Class A Common Stock · traded 12 November 2021 · filed 15 November 2021
- acquired or disposed of, other 247,074 shares of DoximitySEC Form 415 November 2021Class A Common Stock · traded 12 November 2021 · filed 15 November 2021
- acquired or disposed of, other 3,900 shares of GlaukosSEC Form 410 September 2021Common Stock · traded 8 September 2021 · filed 10 September 2021
- acquired or disposed of, other 3,900 shares of GlaukosSEC Form 410 September 2021Common Stock · traded 8 September 2021 · filed 10 September 2021
- acquired or disposed of, other 500,000 shares of PMV PharmaceuticalsSEC Form 414 July 2021Common Stock · traded 13 July 2021 · filed 14 July 2021
- acquired or disposed of, other 97,632 shares of PMV PharmaceuticalsSEC Form 414 July 2021Common Stock · traded 13 July 2021 · filed 14 July 2021
- acquired or disposed of, other 97,632 shares of PMV PharmaceuticalsSEC Form 414 July 2021Common Stock · traded 13 July 2021 · filed 14 July 2021
- acquired or disposed of, other 3,642 shares of PMV PharmaceuticalsSEC Form 414 July 2021Common Stock · traded 13 July 2021 · filed 14 July 2021
- acquired or disposed of, other 2,441 shares of PMV PharmaceuticalsSEC Form 414 July 2021Common Stock · traded 13 July 2021 · filed 14 July 2021
- acquired or disposed of, other 22,148 shares of PMV PharmaceuticalsSEC Form 414 July 2021Common Stock · traded 13 July 2021 · filed 14 July 2021
- converted 13,296,504 shares of Doximity (a derivative holding)SEC Form 428 June 2021Series A Preferred Stock · traded 28 June 2021 · filed 28 June 2021
- converted 5,412,972 shares of Doximity (a derivative holding)SEC Form 428 June 2021Series B Preferred Stock · traded 28 June 2021 · filed 28 June 2021
- converted 2,736,772 shares of Doximity (a derivative holding)SEC Form 428 June 2021Series C Preferred Stock · traded 28 June 2021 · filed 28 June 2021
- converted 21,446,248 shares of Doximity (a derivative holding)SEC Form 428 June 2021Class B Common Stock · traded 28 June 2021 · filed 28 June 2021
- converted 4,289,250 shares of Doximity (a derivative holding)SEC Form 428 June 2021Class B Common Stock · traded 28 June 2021 · filed 28 June 2021
- converted 4,289,250 shares of DoximitySEC Form 428 June 2021Class A Common Stock · traded 28 June 2021 · filed 28 June 2021
- ▼ sold on the open market 4,289,250 shares of DoximitySEC Form 428 June 2021Class A Common Stock · traded 28 June 2021 · filed 28 June 2021
- exercised options over 850 shares of Staar Surgical Co (a derivative holding)SEC Form 425 June 2021Common Stock Options · traded 24 June 2021 · filed 25 June 2021
- was granted 404 shares of Staar Surgical CoSEC Form 425 June 2021Common Stock · traded 24 June 2021 · filed 25 June 2021
- was granted 2,382 shares of GlaukosSEC Form 47 June 2021Common Stock · traded 3 June 2021 · filed 7 June 2021
- acquired or disposed of, other 300,000 shares of GlaukosSEC Form 45 March 2021Common Stock · traded 3 March 2021 · filed 5 March 2021
- acquired or disposed of, other 3,000 shares of GlaukosSEC Form 45 March 2021Common Stock · traded 3 March 2021 · filed 5 March 2021
- acquired or disposed of, other 3,000 shares of GlaukosSEC Form 45 March 2021Common Stock · traded 3 March 2021 · filed 5 March 2021
- acquired or disposed of, other 680 shares of GlaukosSEC Form 45 March 2021Common Stock · traded 3 March 2021 · filed 5 March 2021
- was granted 980 shares of GlaukosSEC Form 46 January 2021Common Stock · traded 4 January 2021 · filed 6 January 2021
- converted 1,620,101 shares of PMV Pharmaceuticals (a derivative holding)SEC Form 42 October 2020Series Seed Preferred Stock · traded 29 September 2020 · filed 2 October 2020
- converted 3,488,398 shares of PMV Pharmaceuticals (a derivative holding)SEC Form 42 October 2020Series A Preferred Stock · traded 29 September 2020 · filed 2 October 2020
- converted 1,040,654 shares of PMV Pharmaceuticals (a derivative holding)SEC Form 42 October 2020Series B Preferred Stock · traded 29 September 2020 · filed 2 October 2020
- converted 265,203 shares of PMV Pharmaceuticals (a derivative holding)SEC Form 42 October 2020Series C Preferred Stock · traded 29 September 2020 · filed 2 October 2020
- ▲ bought on the open market 55,555 shares of PMV PharmaceuticalsSEC Form 42 October 2020Common Stock · traded 25 September 2020 · filed 2 October 2020
- converted 1,620,101 shares of PMV PharmaceuticalsSEC Form 42 October 2020Common Stock · traded 29 September 2020 · filed 2 October 2020
- converted 3,488,398 shares of PMV PharmaceuticalsSEC Form 42 October 2020Common Stock · traded 29 September 2020 · filed 2 October 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.